BioCentury
ARTICLE | Clinical News

AEM-28: Phase Ib/IIa ongoing

June 16, 2014 7:00 AM UTC

LipimetiX Development LLC began the multiple ascending-dose portion of a double-blind, placebo-controlled, Australian Phase Ib/IIa trial of IV AEM-28 in 15 patients with refractory hypercholesterolemi...